文献速递乳腺乳腺X线USMR

北卡罗来纳州乳腺密度告知立法后补充乳腺影像的使用情况

Supplemental Breast Imaging Utilization After Breast Density Legislation in North Carolina.
PubMed 文献 · J Am Coll Radiol · 2019-07-01

研究基于卡罗莱纳乳腺摄影登记库中40至79岁、无乳腺癌或乳房植入物病史的女性,比较2012至2013年与2014至2016年乳腺密度告知法实施前后补充筛查的使用情况。结果显示,无论乳腺密度如何,告知法实施前后补充筛查使用率相似(致密乳腺aOR 1.01,95%CI 0.58-1.75;非致密乳腺aOR 0.63,95%CI 0.38-1.04),但致密乳腺女性新使用任何筛查性DBT的增幅更大(aOR 1.15,95%CI 1.08-1.23)。

要点

  • 乳腺密度告知法实施前后,致密与非致密乳腺女性的补充筛查使用率均无显著变化。
  • 2014至2016年间,致密乳腺女性新使用任何筛查性DBT的增幅大于非致密乳腺女性(aOR 1.15)。
  • 补充筛查定义为筛查乳腺摄影阴性或良性结果后3个月内进行的非诊断性DBT、全乳腺超声或乳腺MRI。

核心结论

  • 数据提示北卡罗来纳州乳腺密度告知法颁布后补充筛查使用情况未发生改变,但致密乳腺女性新使用任何筛查性DBT的增幅更大;在制定更多告知法时应考虑补充筛查短期内未发生变化这一情况。

研究设计与样本

  • 基于卡罗莱纳乳腺摄影登记库的观察性研究,纳入40至79岁、无乳腺癌或乳房植入物个人史的女性,共78,967名女性接受145,279次索引筛查乳腺摄影检查,比较2012-2013年与2014-2016年告知法实施前后补充筛查使用情况,采用逻辑回归分析。

诊断标准与关键数值

  • 补充筛查定义为筛查乳腺摄影(2-D或DBT)阴性或良性结果后3个月内进行的非诊断性DBT、全乳腺超声或乳腺MRI;致密乳腺女性告知法前后补充筛查aOR 1.01(95%CI 0.58-1.75),非致密乳腺女性aOR 0.63(95%CI 0.38-1.04);致密乳腺对比非致密乳腺新使用任何筛查性DBT的aOR 1.15(95%CI 1.08-1.23)。

临床应用与阅片要点

  • 作者认为在制定更多告知法时应考虑补充筛查短期内未发生变化这一情况。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Breast density notification laws are increasingly common but little is known of how they affect supplemental screening use. The aim of this study was to investigate supplemental screening before and after density notification in North Carolina, where notification has been required since 2014.

METHODS: Breast screening data from Carolina Mammography Registry participants aged 40 to 79 years with no personal histories of breast cancer or breast implants were evaluated. Supplemental screening was defined as a nondiagnostic digital breast tomosynthesis (DBT), whole-breast ultrasound, or breast MRI performed within 3 months of negative or benign results on screening mammography (2-D or DBT). Supplemental screening before (2012-2013) and after (2014-2016) the notification law was compared using logistic regression.

RESULTS: During the study period, 78,967 women underwent 145,279 index screening mammographic examinations. Supplemental screening use was similar before and after the notification law, regardless of breast density (dense breasts: adjusted odds ratio [aOR], 1.01; 95% confidence interval [CI], 0.58-1.75; nondense breasts: aOR, 0.63; 95% CI, 0.38-1.04). Although there was no change in supplemental screening, new use of any screening DBT from 2014 to 2016 was greater for women with dense breasts (versus nondense breasts; aOR, 1.15; 95% CI, 1.08-1.23).

CONCLUSIONS: Data suggest that supplemental screening use in North Carolina did not change after enactment of a breast density notification law, though the increase in new use of any screening DBT was greater for women with dense breasts. The short-term lack of change in supplemental screening should be considered as additional notification laws are developed.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Nyante SJ, Marsh MW, Benefield T, et al. Supplemental Breast Imaging Utilization After Breast Density Legislation in North Carolina. J Am Coll Radiol. 2019. PMID: 31271735. doi:10.1016/j.jacr.2019.05.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。